F
$ Value
$73K
Shares
17,584
Price
$4
Filed
Nov 19
Insider
Name
Khan Najat
Title
Chief R&D Commercial Officer
CIK
0002020969
Roles
Director
Officer
Transaction Details
Transaction Date
2025-11-17
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
735,538
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Filing Info
Khan Najat's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-22 | RXRX | ▼ | $549K |
| 2025-11-17 | RXRX | F | $73K |
| 2025-11-05 | RXRX | A | $0 |
| 2025-11-05 | RXRX | A | $0 |
| 2025-08-18 | RXRX | ▼ | $202K |
| 2025-08-15 | RXRX | F | $21K |
| 2025-05-15 | RXRX | F | $16K |
Other Insiders at RXRX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Taylor Ben R
Chief Financial Officer
|
— | — | 2026-04-06 |
| Li Dean Y | — | — | 2026-04-01 |
| Dar Zavain | — | — | 2026-04-01 |
| Borgeson Blake | — | $93K | 2026-04-07 |
| Gibson Christopher | — | $254K | 2026-04-07 |